BNTC - CIK 0001808898
The table below shows Benitec Biopharma Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $97.74M | $50.87M | $2.48M | $4.06M | $19.77M | $9.80M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $98.52M |
| $51.67M |
| $3.73M |
| $4.82M |
| $20.61M |
| $10.81M |
| Property, plant & equipment | $131.00K | $179.00K | $87.00K | $222.00K | $375.00K | $374.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $99.59M | $52.21M | $4.46M | $5.97M | $21.38M | $11.59M |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $1.80M | $4.92M | $3.98M | $2.53M | $1.37M | $1.14M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $2.30M | $4.96M | $4.26M | $3.09M | $1.37M | $1.35M |
| Retained earnings | -$228.18M | -$190.26M | -$167.89M | -$148.33M | -$130.12M | -$116.64M |
| Total equity | $97.30M | $47.25M | $202.00K | $2.88M | $20.01M | $10.24M |